Compare TFX & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TFX | OWL |
|---|---|---|
| Founded | 1943 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.9B |
| IPO Year | 1994 | 2020 |
| Metric | TFX | OWL |
|---|---|---|
| Price | $151.28 | $9.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 18 |
| Target Price | ★ $154.00 | $12.92 |
| AVG Volume (30 Days) | 735.9K | ★ 21.1M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | 0.91% | ★ 8.64% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.08 | 0.07 |
| Revenue | ★ $1,992,713,000.00 | $567,754,000.00 |
| Revenue This Year | $13.81 | $0.62 |
| Revenue Next Year | $4.33 | $9.70 |
| P/E Ratio | ★ $72.13 | $152.14 |
| Revenue Growth | N/A | ★ 7.56 |
| 52 Week Low | $100.18 | $7.95 |
| 52 Week High | $150.04 | $17.00 |
| Indicator | TFX | OWL |
|---|---|---|
| Relative Strength Index (RSI) | 78.14 | 63.93 |
| Support Level | $128.36 | $8.49 |
| Resistance Level | N/A | $10.83 |
| Average True Range (ATR) | 4.07 | 0.42 |
| MACD | 1.52 | 0.20 |
| Stochastic Oscillator | 100.00 | 84.07 |
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
Blue Owl Capital is one of the world's largest alternative-asset managers, $307.4 billion in total managed assets, including $187.7 billion in fee-earning AUM, at the end of 2025. The company has three core business segments: global private equity, (with $69.1 billion in total AUM and $39.5 billion in fee-earning AUM), private credit ($157.7 billion/$99.5 billion), and real estate/real assets ($80.6 billion/$48.7 billion). The firm primarily serves institutional investors (68% of AUM) and high-net-worth individuals (32%). Blue Owl operates through more than 20 offices in the Americas, and the EMEA and Asia-Pacific regions.